We downloaded dataset GSE84422 and extracted the mRNA expression data of MEF2A, and then compared different neuropathological categories of the sample (Figure 3D) and found no significant difference in the possible AD group compared with the control group; in addition, the definite AD group showed a significant difference (p < 0.05). Here, MEF2A is linked to Alzheimer disease.